Review in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
11 authors.
Antônio BragaDepartment of Gynecology and Obstetrics, School of Medicine, Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro 22240-003, RJ, Brazil.ORCID 0000-0002-2942-6182
Jorge de Rezende-FilhoDepartment of Gynecology and Obstetrics, School of Medicine, Maternity School, Federal University of Rio de Janeiro, Rio de Janeiro 22240-003, RJ, Brazil.ORCID 0000-0002-2193-3374
Maurício MagalhãesNational Academy of Medicine, Rio de Janeiro 20021-130, RJ, Brazil.
Sue Yazaki SunDepartment of Obstetrics, Paulista School of Medicine, Federal University of São Paulo, São Paulo 04023-062, SP, Brazil.ORCID 0000-0001-6573-7386
Andreia Cristina de MeloDivision of Clinical Research and Technological Development, Brazilian National Cancer Institute, Rio de Janeiro 20231-050, RJ, Brazil.ORCID 0000-0002-1201-4333
Gustavo Yano CalladoFaculdade Israelita de Ciências da Saúde Albert Einstein, Hospital Israelita Albert Einstein, São Paulo 05652-900, SP, Brazil.ORCID 0000-0001-6694-6569
Fernanda da Costa NegraesService of Gynecology and Obstetrics, Antônio Pedro University Hospital, Federal Fluminense University, Niterói 24070-090, RJ, Brazil.ORCID 0000-0002-1068-9580
Maria Vitória Moura FajardoService of Gynecology and Obstetrics, Antônio Pedro University Hospital, Federal Fluminense University, Niterói 24070-090, RJ, Brazil.
Susana Cristina Aidé Viviani FialhoDepartment of Maternal and Child Health, School of Medicine, Federal Fluminense University, Niterói 24070-090, RJ, Brazil.ORCID 0000-0002-4212-0022
Edward Araujo JúniorDepartment of Obstetrics, Paulista School of Medicine, Federal University of São Paulo, São Paulo 04023-062, SP, Brazil.ORCID 0000-0002-6145-2532
Glória CalagnaVilla Sofia Cervello Hospital, University of Palermo, 90100 Palermo, Italy.ORCID 0000-0002-5301-986X
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
PubMed holds no abstract for this paper.
Indexed as
cancer in pregnancychemotherapy during pregnancygestational cancermultidisciplinary careobstetric oncologyplacental metastasis
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Cancer in Pregnancy: Therapeutic Decisions at the Intersection of Two Lives. · full record | OpenQuestion